Aduhelm
Drug / Medication
A drug approved for early Parkinson's Disease, despite advisory committee's unanimous vote against it due to lack of meaningful benefit and increased risk of brain swelling/bleeding; a key example of problematic FDA approval.
Mentioned in 1 video
